TG Therapeutics - 9 Year Stock Price History | TGTX

Historical daily share price chart and data for TG Therapeutics since 2010 adjusted for splits. The latest closing stock price for TG Therapeutics as of August 20, 2019 is 6.68.
  • The all-time high TG Therapeutics stock price is 225.00, which is 3268.3% above the current share price.
  • The TG Therapeutics 52-week high stock price is 12.70, which is 90.1% above the current share price.
  • The TG Therapeutics 52-week low stock price is 3.44, which is 48.5% below the current share price.
  • The average TG Therapeutics stock price for the last 52 weeks is 6.66.
TG Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 6.7331 4.3100 8.9900 4.0200 6.6800 62.93%
2018 10.7275 8.7500 16.8000 3.4400 4.1000 -50.00%
2017 9.6344 4.4500 14.4500 4.2000 8.2000 76.34%
2016 7.2823 11.4100 11.4100 4.6500 4.6500 -61.02%
2015 14.6154 16.3300 18.8200 9.7600 11.9300 -24.68%
2014 8.6932 4.1000 18.2500 4.1000 15.8400 306.15%
2013 5.1071 3.7000 7.4900 3.1700 3.9000 7.14%
2012 5.1721 1.1250 33.1914 1.1250 3.6400 223.56%
2011 28.2336 56.2500 84.3750 1.1250 1.1250 -98.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.648B $0.000B
TG Therapeutics, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The Company is focused on the development of a monoclonal antibody for the treatment of various B-cell proliferative disorders including lymphoma, leukemia, and auto-immune diseases. TG Therapeutics, Inc., formerly known as Manhattan Pharmaceuticals, Inc., is based in New York.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $151.219B 28.42
Medtronic (MDT) Ireland $139.722B 19.96
Stryker (SYK) United States $81.794B 28.28
Boston Scientific (BSX) United States $59.536B 28.88
Baxter (BAX) United States $44.863B 27.20
EssilorLuxottica Societe Anonyme (ESLOY) France $31.074B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.448B 18.21
Coloplast (CLPBY) Denmark $26.704B 42.63
Lonza Group Ag (LZAGY) Switzerland $26.310B 0.00
Terumo (TRUMY) Japan $23.667B 27.21
Smith & Nephew SNATS (SNN) United Kingdom $20.451B 0.00
ResMed (RMD) United States $19.539B 37.26
Sunny Optical Technology (SNPTF) China $14.084B 0.00
Bio-Rad Laboratories (BIO) United States $9.862B 52.87
Canopy Growth (CGC) Canada $9.263B 0.00
Insulet (PODD) United States $9.194B 544.79
William Demant Holdings (WILYY) Denmark $7.136B 0.00
Hill-Rom Holdings (HRC) United States $7.053B 21.03
Haemonetics (HAE) United States $6.935B 52.33
Perrigo (PRGO) Ireland $6.404B 11.80
Aurora Cannabis (ACB) Canada $5.942B 58.40
GN STORE NORD (GNNDY) Denmark $5.897B 30.11
GW Pharmaceuticals (GWPH) United Kingdom $4.650B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $3.753B 62.43
ICU Medical (ICUI) United States $3.439B 22.31
NuVasive (NUVA) United States $3.331B 26.56
Hutchison China MediTech (HCM) China $2.666B 0.00
Agios Pharmaceuticals (AGIO) United States $2.562B 0.00
Quidel (QDEL) United States $2.554B 25.36
National Vision Holdings (EYE) United States $2.159B 46.61
Cardiovascular Systems (CSII) United States $1.736B 0.00
Aphria (APHA) $1.566B 0.00
Phibro Animal Health (PAHC) United States $1.291B 19.34
AtriCure (ATRC) United States $1.066B 0.00
VAREX IMAGING (VREX) United States $1.036B 23.87
Omeros (OMER) United States $1.013B 0.00
NanoString Technologies (NSTG) United States $1.001B 0.00
PetIQ (PETQ) United States $0.921B 21.75
Lantheus Holdings (LNTH) United States $0.917B 24.09
Eagle Pharmaceuticals (EGRX) United States $0.805B 20.53
Cerus (CERS) United States $0.782B 0.00
MacroGenics (MGNX) United States $0.742B 0.00
Quanterix (QTRX) United States $0.683B 0.00
LeMaitre Vascular (LMAT) United States $0.625B 37.06
Surmodics (SRDX) United States $0.619B 117.64
OraSure Technologies (OSUR) United States $0.449B 20.77
Meridian Bioscience (VIVO) United States $0.431B 13.44
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.403B 0.00
BioLife Solutions (BLFS) United States $0.384B 126.25
United Health Products (UEEC) United States $0.378B 0.00
Utah Medical Products (UTMD) United States $0.347B 25.43
Zynex (ZYXI) United States $0.334B 35.48
Owens & Minor (OMI) United States $0.312B 9.36
Bovie Medical (APYX) United States $0.261B 0.00
Vapotherm (VAPO) United States $0.245B 0.00
Rockwell Medical (RMTI) United States $0.161B 0.00
Cytosorbents (CTSO) United States $0.157B 0.00
Chimerix (CMRX) United States $0.155B 0.00
Fonar (FONR) United States $0.152B 7.97
Female Health (VERU) United States $0.126B 0.00
InfuSystems Holdings (INFU) United States $0.095B 0.00
Chembio Diagnostics (CEMI) United States $0.094B 0.00
United-Guardian (UG) United States $0.088B 20.71
Surface Oncology (SURF) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.057B 0.00
Nephros (NEPH) United States $0.054B 0.00
MRI INTERVENTNS (MRIC) United States $0.046B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Trinity Biotech (TRIB) Ireland $0.041B 14.33
Senestech (SNES) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.012B 0.00
Myomo (MYO) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
GUARDION HEALTH (GHSI) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00